INIS
Price
$0.07
Change
-$0.01 (-12.50%)
Updated
Sep 4 closing price
Capitalization
37.02M
IPSEF
Price
$113.13
Change
+$9.63 (+9.30%)
Updated
Jun 9 closing price
Capitalization
11.56B
Interact to see
Advertisement

INIS vs IPSEF

Header iconINIS vs IPSEF Comparison
Open Charts INIS vs IPSEFBanner chart's image
International Isotopes
Price$0.07
Change-$0.01 (-12.50%)
Volume$342.66K
Capitalization37.02M
Ipsen S.A
Price$113.13
Change+$9.63 (+9.30%)
Volume$150
Capitalization11.56B
INIS vs IPSEF Comparison Chart in %
Loading...
INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INIS vs. IPSEF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INIS is a Hold and IPSEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (INIS: $0.07 vs. IPSEF: $113.13)
Brand notoriety: INIS and IPSEF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INIS: 263% vs. IPSEF: 100%
Market capitalization -- INIS: $37.02M vs. IPSEF: $11.56B
INIS [@Pharmaceuticals: Generic] is valued at $37.02M. IPSEF’s [@Pharmaceuticals: Generic] market capitalization is $11.56B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INIS’s FA Score shows that 1 FA rating(s) are green whileIPSEF’s FA Score has 2 green FA rating(s).

  • INIS’s FA Score: 1 green, 4 red.
  • IPSEF’s FA Score: 2 green, 3 red.
According to our system of comparison, IPSEF is a better buy in the long-term than INIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INIS’s TA Score shows that 4 TA indicator(s) are bullish.

  • INIS’s TA Score: 4 bullish, 4 bearish.

Price Growth

INIS (@Pharmaceuticals: Generic) experienced а -12.37% price change this week, while IPSEF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPSEF($11.6B) has a higher market cap than INIS($37M). INIS YTD gains are higher at: 103.779 vs. IPSEF (-9.763). IPSEF has higher annual earnings (EBITDA): 1.3B vs. INIS (855K). IPSEF has more cash in the bank: 1.45B vs. INIS (1.86M). INIS has less debt than IPSEF: INIS (4.82M) vs IPSEF (869M). IPSEF has higher revenues than INIS: IPSEF (3.76B) vs INIS (14.7M).
INISIPSEFINIS / IPSEF
Capitalization37M11.6B0%
EBITDA855K1.3B0%
Gain YTD103.779-9.763-1,063%
P/E RatioN/A18.07-
Revenue14.7M3.76B0%
Total Cash1.86M1.45B0%
Total Debt4.82M869M1%
FUNDAMENTALS RATINGS
INIS vs IPSEF: Fundamental Ratings
INIS
IPSEF
OUTLOOK RATING
1..100
6447
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
26
Undervalued
PROFIT vs RISK RATING
1..100
9735
SMR RATING
1..100
8891
PRICE GROWTH RATING
1..100
5359
P/E GROWTH RATING
1..100
622
SEASONALITY SCORE
1..100
9010

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPSEF's Valuation (26) in the null industry is somewhat better than the same rating for INIS (83). This means that IPSEF’s stock grew somewhat faster than INIS’s over the last 12 months.

IPSEF's Profit vs Risk Rating (35) in the null industry is somewhat better than the same rating for INIS (97). This means that IPSEF’s stock grew somewhat faster than INIS’s over the last 12 months.

INIS's SMR Rating (88) in the null industry is in the same range as IPSEF (91). This means that INIS’s stock grew similarly to IPSEF’s over the last 12 months.

INIS's Price Growth Rating (53) in the null industry is in the same range as IPSEF (59). This means that INIS’s stock grew similarly to IPSEF’s over the last 12 months.

INIS's P/E Growth Rating (6) in the null industry is in the same range as IPSEF (22). This means that INIS’s stock grew similarly to IPSEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INISIPSEF
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
17%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
13%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 23 days ago
83%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HPI16.350.15
+0.93%
John Hancock Preferred Income Fund
JBND54.120.26
+0.48%
JPMorgan Active Bond ETF
AIEQ43.86-0.12
-0.28%
Amplify AI Powered Equity ETF
NRSH21.60-0.06
-0.29%
Aztlan NA Nearshoring Stk Sel ETF
LRGG29.56-0.31
-1.04%
Macquarie Focused Large Growth ETF

INIS and

Correlation & Price change

A.I.dvisor tells us that INIS and HLTRF have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INIS and HLTRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INIS
1D Price
Change %
INIS100%
N/A
HLTRF - INIS
17%
Poorly correlated
N/A
GRUSF - INIS
10%
Poorly correlated
-0.25%
HSTI - INIS
9%
Poorly correlated
N/A
HYPMY - INIS
3%
Poorly correlated
+1.57%
IPSEF - INIS
2%
Poorly correlated
N/A
More

IPSEF and

Correlation & Price change

A.I.dvisor tells us that IPSEF and TEVJF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPSEF and TEVJF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSEF
1D Price
Change %
IPSEF100%
N/A
TEVJF - IPSEF
24%
Poorly correlated
N/A
IPSEY - IPSEF
6%
Poorly correlated
+3.39%
JUSHF - IPSEF
6%
Poorly correlated
+6.59%
INDV - IPSEF
5%
Poorly correlated
+1.01%
INIS - IPSEF
2%
Poorly correlated
N/A
More